Vet Med - Czech, 2016, 61(5):237-242 | DOI: 10.17221/8876-VETMED

Therapeutic effects of a combined antibiotic-enzyme treatment on subclinical mastitis in lactating dairy cowsOriginal Paper

B. Khoramian1, M. Emaneini2, M. Bolourchi3, A. Niasari-Naslaji3, A. Gorganzadeh1, S. Abani1, P. Hovareshti3
1 Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran
2 School of Medicine, Tehran University of Medical Sciences. Tehran, Iran
3 Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran

ABSTRACT: The objective of this study was to evaluate a combined antibiotic-enzyme therapy for Staphylococcus aureus mastitis and biofilm formation. A total of 141 cases of S. aureus chronic mastitis from three farms were divided into two groups: the control group (n = 54) were treated with Nafpenzal® ointment; the enzyme + antibiotic group (n = 87) were treated with Nafpenzal® plus an enzymatic ointment (MastiVeyxym®). Quantitative determination of biofilm formation was determined using a colorimetric microplate assay and the detection of ica genes by PCR. Enzyme + antibiotic therapy did not significantly improve cure rates compared to control (48.3 vs 38.9%). The cure rate for infections caused by biofilm-positive strains was 42.6 and 46.6% for control and enzyme + antibiotic groups, respectively (P > 0.05). Comparison of cure rates between farms showed a relationship with somatic cell count (SCC), parity and oxacillin resistance. 79.4% of the isolates produced biofilm and antibacterial resistance rates for oxacillin, penicillin and streptomycin were 25.5, 71.6 and 95.7%, respectively. These results indicate that while the increase in mastitis cure rate using enzymatic therapy was not significant, this treatment could be useful in some situations.

Keywords: mastitis; Staphylococcus aureus; biofilm; enzyme-antibiotic treatment; genomic DNA; ica genes

Published: May 31, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Khoramian B, Emaneini M, Bolourchi M, Niasari-Naslaji A, Gorganzadeh A, Abani S, Hovareshti P. Therapeutic effects of a combined antibiotic-enzyme treatment on subclinical mastitis in lactating dairy cows. Vet Med - Czech. 2016;61(5):237-242. doi: 10.17221/8876-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arciola CR, Baldassarri L, Montanaro L (2001): Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. Journal of Clinical Microbiology 39, 2151-2156. Go to original source... Go to PubMed...
    2. Berg ICH, Kalfas S, Malmsten M, Arnebrant T (2001): Proteolytic degradation of oral biofilms in vitro and in vivo: potential of proteases originating from Euphasia superba for plaque control. European Journal of Oral Sciences 109, 316-324. Go to original source... Go to PubMed...
    3. Castelani L, Pilon LE, Martins T, Pozzi CR, Arcaro JR (2015): Investigation of biofilm production and icaA and icaD genes in Staphylococcus aureus isolated from heifers and cows with mastitis. Animal Science Journal 86, 340-344. Go to original source... Go to PubMed...
    4. Chaignon P, Sadovskaya I, Ragunath C, Ramasubbu N, Kaplan JB, Jabbouri S (2007): Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Applied Microbiology and Biotechnology 75, 125-132. Go to original source... Go to PubMed...
    5. Czaczyk K, Myszka K (2007): Biosynthesis of extracellular polymeric substances (EPS) and its role in microbial biofilm formation. Polish Journal of Environmental Studies 16, 799-806.
    6. Davey ME, O'Toole GA (2000): Microbial biofilms: from ecology to molecular genetics. Microbiology and Molecular Biology Reviews 64, 847-867. Go to original source... Go to PubMed...
    7. Gotz F (2002): Staphylococcus and biofilms. Molecular Microbiology 43, 1367-1378. Go to original source... Go to PubMed...
    8. Grinholc M, Wegrzyn G, Kurlenda J (2007): Evaluation of biofilm production and prevalence of the icaD gene in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains isolated from patients with nosocomial infections and carriers. FEMS Immunology and Medical Microbiology 50, 375-379. Go to original source... Go to PubMed...
    9. Johansen C, Falholt P, Gram L (1997): Enzymatic removal and disinfection of bacterial biofilms. Applied and Environmental Microbiology 63, 3724-3728. Go to original source... Go to PubMed...
    10. Kaplan JB, Ragunath C, Velliyagounder K, Fine DH, Ramasubbu N (2004): Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrobial Agents and Chemotherapy 48, 2633-2636. Go to original source... Go to PubMed...
    11. Khoramian B, Jabalameli F, Niasari-Naslaji A, Taherikalani M, Emaneini M (2015): Comparison of virulence factors and biofilm formation among Staphylococcus aureus strains isolated from human and bovine infections. Microbial Pathogenesis 88, 73-77. Go to original source... Go to PubMed...
    12. Kokai-Kun JF, Chanturiya T, Mond JJ (2009): Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice. Journal of Antimicrobial Chemotherapy 64, 94-100. Go to original source... Go to PubMed...
    13. Krewer CD, Amanso ES, Gouveia GV, Souza RD, da Costa MM, Mota RA (2015): Resistance to antimicrobials and biofilm formation in Staphylococcus spp. isolated from bovine mastitis in the Northeast of Brazil. Tropical Animal Health and Production 47, 511-518. Go to original source... Go to PubMed...
    14. Leslie AD (2011): Preventing biofilm formation using microbes and their enzymes. MMG 445 Basic Biotechnology 7, 6-11.
    15. Lu TK, Collins JJ (2007): Dispersing biofilms with engineered enzymatic bacteriophage. Proceedings of the National Academy of Sciences of the United States of America 104, 11197-11202. Go to original source... Go to PubMed...
    16. Mecikoglu M, Saygi B, Yildirim Y, Karadag-Saygi E, Ramadan SS, Esemenli T (2006): The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection. Journal of Bone and Joint Surgery-American 88, 1208-1214. Go to original source... Go to PubMed...
    17. Melchior MB, Vaarkamp H, Fink-Gremmels J (2006): Biofilms: A role in recurrent mastitis infections. Veterinary Journal 171, 398-407. Go to original source... Go to PubMed...
    18. Molobela IP, Cloete TE, Beukes M (2010): Protease and amylase enzymes for biofilm removal and degradation of extracellular polymeric substances (EPS) produced by Pseudomonas fluorescens bacteria. African Journal of Microbiology Research 4, 1515-1524.
    19. Parsek MR, Fuqua C (2004): Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life. Journal of Bacteriology 186, 4427-4440. Go to original source... Go to PubMed...
    20. Peeters E, Nelis HJ, Coenye T (2008): Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. Journal of Microbiological Methods 72, 157-165. Go to original source... Go to PubMed...
    21. Sahebekhtiari N, Nochi Z, Eslampour MA, Dabiri H, Bolfion M, Taherikalani M, Khoramian B, Zali MR, Emaneini M (2011): Characterization of Staphylococcus aureus strains isolated from raw milk of bovine subclinical mastitis in Tehran and Mashhad. Acta Microbiologica et Immunologica Hungarica 58, 113-121. Go to original source... Go to PubMed...
    22. Selan L, Berlutti F, Passariello C, Comodi-Ballanti MR, Thaller MC (1993): Proteolytic enzymes: a new treatment strategy for prosthetic infections. Antimicrobial Agents and Chemotherapy 37, 2618-2621. Go to original source... Go to PubMed...
    23. Snel GG, Malvisi M, Pilla R, Piccinini R (2014): Evaluation of biofilm formation using milk in a flow cell model and microarray characterization of Staphylococcus aureus strains from bovine mastitis. Veterinary Microbiology 174, 489-495. Go to original source... Go to PubMed...
    24. Vasudevan P, Nair MK, Annamalai T, Venkitanarayanan KS (2003): Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Veterinary Microbiology 92, 179-185. Go to original source... Go to PubMed...
    25. Walencka E, Sadowska B, Rozalska S, Hryniewicz W, Rozalska B (2005): Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Polish Journal of Microbiology 54, 191-200.
    26. Walencka E, Sadowska B, Rozalska S, Hryniewicz W, Rozalska B (2006): Staphylococcus aureus biofilm as a target for single or repeated doses of Oxacillin, Vancomycin, Linezolid and/or Lysostaphin. Folia Microbiologica 51, 381-386. Go to original source... Go to PubMed...
    27. Zecconi A, Cesaris L, Liandris E, Dapra V, Piccinini R (2006): Role of several Staphylococcus aureus virulence factors on the inflammatory response in bovine mammary gland. Microbial Pathogenesis 40, 177-183. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content